UBS Group’s Intellinetics INLX Stock Holding History

UBS Group’s Portfolio INLX Stock Details INLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.42K	Buy	858 +857	+85,700%	+$4.72K	﹤0.01%	9672
2026 Q2	$6	Sell	1 -265	-100%	-$1.77K	﹤0.01%	10342
2026 Q1	$1.98K	Sell	266 -105	-28%	-$819	﹤0.01%	9389
2025 Q4	$2.96K	Sell	371 -3,226	-90%	-$29.8K	﹤0.01%	9174
2025 Q3	$40.6K	Buy	3,597 +3,596	+359,600%	+$42.1K	﹤0.01%	7709
2025 Q2	$13	Hold	1	–	–	﹤0.01%	10140
2025 Q1	$12	Hold	1	–	–	﹤0.01%	10112
2024 Q4	$14	Hold	1	–	–	﹤0.01%	9794
2024 Q3	$11	Hold	1	–	–	﹤0.01%	9350
2024 Q2	$6	Buy	+1	New	+$7	﹤0.01%	9387
2024 Q1	–	Sell	-572	Closed	-$2.89K	–	9653
2023 Q4	$2.89K	Buy	+572	New	+$2.53K	﹤0.01%	8040

Other funds holding INLX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group's INLX Position: Q3 2026 in Review

UBS Group increased its Intellinetics (INLX) stake by 85,700% in Q3 2026, buying an estimated $4.72K and bringing the position to 858 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #9672.

UBS Group first reported a position in INLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $40.6K in Q3 2025. 3 funds tracked by Wall St. Rank hold INLX as of Q3 2026.

UBS Group held 858 shares of Intellinetics worth $4.42K as of Q3 2026.
UBS Group bought 857 Intellinetics shares in Q3 2026, an estimated $4.72K.
Intellinetics made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9672 holding.
UBS Group first reported a position in Intellinetics in Q4 2023 and has held it in 11 quarters since.
UBS Group's Intellinetics position peaked at $40.6K in Q3 2025.
3 funds tracked by Wall St. Rank held Intellinetics as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.